Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuhui Chen

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Annals of Neurology|December 27, 2024
Prediction of Central Post-Stroke Pain by Quantitative Sensory TestingSusanna Asseyer, Eleni Panagoulas, Jana Maidhof, et al.
Biochemical Pharmacology|February 14, 2025
Tamibarotene directly targets the NACHT domain of NLRP3 to alleviate acute myocardial infarctionXiuhui Chen, Yunjing Wang, Junjun Huang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 16, 2018
The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host DiseaseBo Tang, Xue Li, Yuanlin Liu, et al.
Biochemical Pharmacology|November 3, 2022
Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammationXiuhui Chen, Yanhong Chen, Yitao Ou, et al.
European Journal of Pharmacology|July 22, 2022
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in miceShuli Liang, Zhongjin Yang, Lei Hua, et al.
Toxicology and Applied Pharmacology|May 13, 2025
Harnessing FDA-approved dipyridamole to inhibit NLRP3 inflammasome and improve outcomes of acute lung injury in sepsisXiuhui Chen, Yutong Zheng, Xiaofeng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2021
Discovery of dronedarone and its analogues as NLRP3 inflammasome inhibitors with potent anti-inflammation activityHao Chen, Xiuhui Chen, Ping Sun, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 11, 2025
Loganin epigenetically rescues mitochondrial complex III dysfunction via DNMT1-UQCRC1 demethylation to halt cardiac remodeling after myocardial infarctionYunjing Wang, Renshan Chen, Huaqian Dou, et al.
Journal of Medicinal Chemistry|September 5, 2022
Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation ActivityXinyi Wu, Ping Sun, Xiuhui Chen, et al.
Chemico-Biological Interactions|August 24, 2022
Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in miceYanhong Chen, Xiuhui Chen, Shuli Liang, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Annals of Neurology|December 27, 2024
Prediction of Central Post-Stroke Pain by Quantitative Sensory TestingSusanna Asseyer, Eleni Panagoulas, Jana Maidhof, et al.
Biochemical Pharmacology|February 14, 2025
Tamibarotene directly targets the NACHT domain of NLRP3 to alleviate acute myocardial infarctionXiuhui Chen, Yunjing Wang, Junjun Huang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 16, 2018
The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host DiseaseBo Tang, Xue Li, Yuanlin Liu, et al.
Biochemical Pharmacology|November 3, 2022
Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammationXiuhui Chen, Yanhong Chen, Yitao Ou, et al.
European Journal of Pharmacology|July 22, 2022
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in miceShuli Liang, Zhongjin Yang, Lei Hua, et al.
Toxicology and Applied Pharmacology|May 13, 2025
Harnessing FDA-approved dipyridamole to inhibit NLRP3 inflammasome and improve outcomes of acute lung injury in sepsisXiuhui Chen, Yutong Zheng, Xiaofeng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2021
Discovery of dronedarone and its analogues as NLRP3 inflammasome inhibitors with potent anti-inflammation activityHao Chen, Xiuhui Chen, Ping Sun, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 11, 2025
Loganin epigenetically rescues mitochondrial complex III dysfunction via DNMT1-UQCRC1 demethylation to halt cardiac remodeling after myocardial infarctionYunjing Wang, Renshan Chen, Huaqian Dou, et al.
Journal of Medicinal Chemistry|September 5, 2022
Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation ActivityXinyi Wu, Ping Sun, Xiuhui Chen, et al.
Chemico-Biological Interactions|August 24, 2022
Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in miceYanhong Chen, Xiuhui Chen, Shuli Liang, et al.
Pageof 4